Axel Hinke
Impact in
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 100
- Colorectal Cancer Treatments and Studies 44
- Cancer Treatment and Pharmacology 23
- HER2/EGFR in Cancer Research 13
- Pancreatic and Hepatic Oncology Research 13
-
- Gastric Cancer Management and Outcomes 19
- Co-authors
- Volker Heinemann (10 shared papers)Hanno Riess (2 shared papers)Andreas Hochhaus (3 shared papers)Helmut Oettle (2 shared papers)Klaus Gellert (2 shared papers)Jörg Fahlke (1 shared paper)P. Neuhaus (1 shared paper)C. Zülke (1 shared paper)
- Journals
- Journal of Clinical Oncology (56 papers)Blood (15 papers)Annals of Oncology (13 papers)BMC Cancer (11 papers)European Journal of Cancer (7 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Axel Hinke
182 papers receiving 8.6k citations
Axel Hinke's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 4.8k
- Pathology and Forensic Medicine 1.5k
- Genetics 831
- Pulmonary and Respiratory Medicine 2.3k
- Cancer Research 966
Countries citing papers authored by Axel Hinke
This map shows the geographic impact of Axel Hinke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Hinke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Hinke more than expected).
Fields of papers citing papers by Axel Hinke
This network shows the impact of papers produced by Axel Hinke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Hinke. The network helps show where Axel Hinke may publish in the future.
Co-authors
The 25 scholars most cited alongside Axel Hinke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer Hit paper breakdown → | 2013 | 1315 |
| 2 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 1013 |
| 3 | Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95 Hit paper breakdown → | 2009 | 616 |
| 4 | Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer Hit paper breakdown → | 2006 | 552 |
| 5 | Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Hit paper breakdown → | 2011 | 439 |
| 6 | 2008 | 348 | |
| 7 | 2007 | 219 | |
| 8 | 2002 | 185 | |
| 9 | 2015 | 178 | |
| 10 | 2008 | 156 | |
| 11 | 2010 | 135 | |
| 12 | 2008 | 124 | |
| 13 | Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. | 1994 | 123 |
| 14 | 2009 | 116 | |
| 15 | 2015 | 115 | |
| 16 | 2020 | 111 | |
| 17 | 2007 | 111 | |
| 18 | 2009 | 106 | |
| 19 | 2007 | 95 | |
| 20 | 2009 | 79 |
About Axel Hinke
Axel Hinke is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Hematology, having authored 191 papers that have together received 8.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (44 papers), Cancer Treatment and Pharmacology (23 papers), Gastric Cancer Management and Outcomes (19 papers), Lymphoma Diagnosis and Treatment (16 papers), Multiple Myeloma Research and Treatments (14 papers), HER2/EGFR in Cancer Research (13 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Breast Cancer Treatment Studies (12 papers). The work is most often cited by research in Oncology (4.8k citations), Pathology and Forensic Medicine (1.5k citations), Genetics (831 citations), Pulmonary and Respiratory Medicine (2.3k citations) and Cancer Research (966 citations). Axel Hinke has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Volker Heinemann, Hanno Riess, Andreas Hochhaus, Helmut Oettle, Klaus Gellert, Jörg Fahlke, P. Neuhaus, C. Zülke, Marianne Sinn and Marco Niedergethmann. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, BMC Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.